1st Quarter - Report — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2019)

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$1,860,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: Treasury, Dept of; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS)

Veterans VET

Education related to hepatitis C and HIV.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); SENATE; Office of Management & Budget (OMB); Commerce, Dept of (DOC); Treasury, Dept of; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV and oncology products. Medicaid duplicate discounts. Proposed changes to Medicare Part D's six protected classes.

Lobbyist	Covered position, as disclosed
MICHAEL D BOYD New	Legislative Assistant, Rep. Jim Kolbe
CHARLES M. CLAPTON	—
COOKAB HASHEMI	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Budget/Appropriations BUD

Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
COOKAB HASHEMI	—
DAVID PULLIAM	—

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE

Indian/Native American Affairs IND

Education related to hepatitis C and HIV.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Treasury, Dept of; SENATE; State, Dept of (DOS)

Health Issues HCR

Administration drug pricing proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program.

Lobbyist	Covered position, as disclosed
MICHAEL D BOYD New	Legislative Assistant, Rep. Jim Kolbe
CHARLES M. CLAPTON	—
COOKAB HASHEMI	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.